Request Your Free Playbook Now:

"How To Thrive In An Unpredictable Era By Reimagining The Critical Path Through Supply Chain Innovation"

In today’s unpredictable clinical landscape, explore complex challenges and innovative strategies to safely deliver lifesaving advanced treatments to patients.

Unpredictability is now the only certainty. As the industry has been disrupted by everything from pandemics to geopolitical shifts to economic impacts, the rapidly evolving environment has exposed the fragility of traditional clinical trial models with advanced therapy supply chain arguably the most challenging component. After the number of new patients entering studies fell 59% in April 2020, forward-thinking leaders pivoted quickly, developing more patient-centric, agile and resilient supply chains.

This whitepaper will explore key topics such as:

• How unforeseeable events have exposed limitations of supply chains for cell and gene therapies, why developers should expect even more disruptions and how the current challenges represent an opportunity to create more resilient logistics and distribution solutions.  
• How to navigate the complex challenges of scalability and flexibility to successfully bring a therapy to market including supply chain infrastructure, packaging solutions, technology advancements and cargo capacity constraints.
• Critical need for personalized, patient-centric solutions with built in mitigation and contingency strategies and innovative technology to improve the lives of patients and adapt studies to the current environment.
• How taking a proactive approach to planning your commercial supply chain early, seeing the supply chain as a critical path and reorienting logistics around the patient will the turn the task of getting medicines to patients into a competitive advantage.

Offered Free by: Marken
See All Resources from: Marken